Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 10,000 shares at $9.16 ($92K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $92k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |